TY - JOUR
T1 - Imaging-& physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure
T2 - A feasibility, safety, & outcome study
AU - Ali, Ziad A.
AU - Galougahi, Keyvan Karimi
AU - Nazif, Tamim
AU - Maehara, Akiko
AU - Hardy, Mark A.
AU - Cohen, David J.
AU - Ratner, Lloyd E.
AU - Collins, Michael B.
AU - Moses, Jeffrey W.
AU - Kirtane, Ajay J.
AU - Stone, Gregg W.
AU - Karmpaliotis, Dimitri
AU - Leon, Martin B.
N1 - Publisher Copyright:
©The Author 2015.
PY - 2016/10/21
Y1 - 2016/10/21
N2 - Aims The feasibility, safety, and clinical utility of percutaneous coronary intervention (PCI) without radio-contrast medium in patients with advanced chronic kidney disease (CKD) are unknown. In this series, we investigated a specific strategy for 'zero contrast' PCI with the aims of preserving renal function and preventing the need for renal replacement therapy (RRT) in patients with advanced CKD. Methods and results A total of 31 patients with advanced CKD [creatinine 4.2 mg/dL, inter-quartile range (IQR) 3.1-4.8, estimated glomerular filtration rate 16+8 mL/min/1.73 m2] who had clinical indication for PCI based on a prior minimal contrast coronary angiogram were included. Zero contrast PCI was performed at least 1 week after diagnostic angiography using real-Time intravascular ultrasound (IVUS) guidance, with pre-And post-PCI measurements of fractional flow reserve and coronary flow reserve to confirm physiological improvement. This approach resulted in successful PCI, no major adverse cardiovascular events and preservation of renal function without the need for RRT within a follow-up time of 79 days (IQR 33-207) in all patients. Conclusion In patients with advanced CKD who require revascularization, PCI may safely be performed without contrast using IVUS and physiological guidance with high procedural success and without complications.
AB - Aims The feasibility, safety, and clinical utility of percutaneous coronary intervention (PCI) without radio-contrast medium in patients with advanced chronic kidney disease (CKD) are unknown. In this series, we investigated a specific strategy for 'zero contrast' PCI with the aims of preserving renal function and preventing the need for renal replacement therapy (RRT) in patients with advanced CKD. Methods and results A total of 31 patients with advanced CKD [creatinine 4.2 mg/dL, inter-quartile range (IQR) 3.1-4.8, estimated glomerular filtration rate 16+8 mL/min/1.73 m2] who had clinical indication for PCI based on a prior minimal contrast coronary angiogram were included. Zero contrast PCI was performed at least 1 week after diagnostic angiography using real-Time intravascular ultrasound (IVUS) guidance, with pre-And post-PCI measurements of fractional flow reserve and coronary flow reserve to confirm physiological improvement. This approach resulted in successful PCI, no major adverse cardiovascular events and preservation of renal function without the need for RRT within a follow-up time of 79 days (IQR 33-207) in all patients. Conclusion In patients with advanced CKD who require revascularization, PCI may safely be performed without contrast using IVUS and physiological guidance with high procedural success and without complications.
KW - Chronic kidney disease
KW - Contrast-induced nephropathy
KW - Coronary physiology
KW - Intravascular ultrasonography
KW - Percutaneous coronary intervention
UR - http://www.scopus.com/inward/record.url?scp=84989313750&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehw078
DO - 10.1093/eurheartj/ehw078
M3 - Article
C2 - 26957421
AN - SCOPUS:84989313750
SN - 0195-668X
VL - 37
SP - 3090
EP - 3095
JO - European Heart Journal
JF - European Heart Journal
IS - 40
ER -